Abstract

For this installment of From the Pages of Allergy Watch, I have selected articles from the July to August issue. The first, reviewed by Dr Lee, suggests that pretreatment with H1 and H2 antihistamines and montelukast can reduce the risk for reaction to coronavirus disease 2019 (COVID-19) vaccination. The second, reviewed by Dr Hernandez-Trujillo, reports data suggesting that alpha-gal allergy can be a problem even in areas not endemic for the lone star tick. The final article, reviewed by Dr Joshi, presented data suggesting that children with more severe atopic dermatitis are more likely to have learning disabilities.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call